Accessibility Statement Skip Navigation
  • Resources
  • Blog
  • Journalists
  • +44 (0)20 7454 5110
  • Client Login
  • Send a Release
Return to PR Newswire homepage
  • News
  • Products
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All Public Company News
      • All Multimedia News
      • View All News Releases

      • Regulatory News

      • D/A/CH Regulatory News
      • UK Regulatory News
      • View All Regulatory News

  • Business & Money
      • Auto & Transportation

      • Aerospace & Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads & Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking & Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film & Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers & Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalisation
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls & Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil & Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defence
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation & Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking & Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers & Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines & Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics & Personal Care
      • Fashion
      • Food & Beverages
      • Furniture & Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewellery
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film & Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks & Tourist Attractions
      • Gambling & Casinos
      • Hotels & Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Animal Welfare
      • Corporate Social Responsibility
      • Economic News, Trends & Analysis
      • Education
      • Environmental
      • European Government
      • Labour & Union
      • Natural Disasters
      • Not For Profit
      • Public Safety
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Overview
  • Distribution
  • Paid Placement
  • Multimedia
  • Disclosure Services
  • SocialBoost
  • Rooms
    • MediaRoom
    • ESG Rooms
  • AI Tools
  • General Enquiries
  • Media Enquiries
  • Partnerships
  • Hamburger menu
  • Cision PR Newswire UK provides press release distribution, targeting, monitoring, and marketing services
  • Send a Release
    • Phone

    • +44 (0)20 7454 5110 from 8 AM - 5:30 PM GMT

    • ALL CONTACT INFO
    • Contact Us

      +44 (0)20 7454 5110
      from 8 AM - 5:30 PM GMT

  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists
  • News in Focus
    • Browse News Releases
    • Regulatory News
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
    • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists
  • Overview
  • Distribution
  • Paid Placement
  • Multimedia
  • Disclosure Services
  • Cision Communications Cloud®
  • AI Tools
  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists
  • General Enquiries
  • Media Enquiries
  • Partnerships
  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists

Biomarkers Market Is Projected to Witness A Robust Growth At A CAGR Of 14.1% During 2021-2027 | Brandessence Market Research

This image opens in the lightbox

News provided by

Brandessence Market Research and Consulting Private Limited

26 Sep, 2023, 07:46 GMT

Share this article

Share toX

Share this article

Share toX

LONDON, Sept. 26, 2023 /PRNewswire/ -- According to a comprehensive research report by Brandessence Market Research (BMRC), "Biomarkers Market By Product, By Type, By Application, By Disease Indication, Industry Analysis, Trends, And Forecast, 2021-2027" The Biomarkers Market was valued at USD 36.3 Billion in 2018 and expected to reach USD 91.4 Billion By 2025, amplifying with a CAGR of 14.1% over 2021-2027.

Biomarkers Market Overview:

In today's ever-evolving landscape of healthcare and diagnostics, biomarkers have emerged as a pivotal tool. These molecular indicators offer valuable insights into the physiological and pathological processes within the human body. The global biomarkers market has witnessed significant growth over the years, driven by a multitude of factors. In this article, we delve into the scope, segmentation, and market dynamics of the biomarkers market, providing a comprehensive overview of this burgeoning industry.

Biomarkers Market Scope:

Report Metric

Details

Biomarkers Market Revenue forecast in 2025

USD 91.4 Billion

Market Size in 2018

USD 36.3 Billion

Market Growth Rate

CAGR of 14.1% from 2021 to 2027

Base Year

2020

Study Period

2021-2027

Key Players/Companies

Siemens Healthineers, Medtronic, Hoffman LA Roche Ltd., Abbott Laboratories Nexus-DX, Qiagen N.V., PerkinElmer Inc., Lifesign LLC., Merck & Co Inc., Bio-Rad Laboratories, EKF Diagnostics Holdings plc, Singulex Inc., Signosis Inc, BioSims Technologies, among others.


Get Free Sample PDF Brochure:

https://brandessenceresearch.com/downloadSample/PostId/444

The biomarkers market is vast and diverse, encompassing a wide array of applications across various sectors, including healthcare, pharmaceuticals, and diagnostics. Biomarkers are molecules, genes, or characteristics that can be objectively measured and evaluated as indicators of normal biological processes, pathogenic processes, or pharmacologic responses to therapeutic interventions.

Market Dynamics of Biomarkers:

The biomarkers market is marked by dynamic factors that shape its growth and evolution.

Market Drivers:

Advancements in Technology: Technological innovations, such as next-generation sequencing and mass spectrometry, have enhanced biomarker discovery and validation.

Rise in Chronic Diseases: The increasing prevalence of chronic diseases necessitates improved diagnostic and treatment strategies, driving the demand for biomarkers.

Personalized Medicine: The shift toward personalized medicine creates a strong demand for biomarkers to tailor treatments to individual patients.

Drug Development: Biomarkers streamline drug development, reducing costs and time, making them indispensable to pharmaceutical companies.

Market Challenges:

Regulatory Hurdles: The validation and approval of biomarkers by regulatory agencies can be a lengthy and costly process.

Ethical Concerns: Privacy and ethical concerns regarding the use of genetic and personal data in biomarker research remain a challenge.

Complexity of Diseases: Many diseases are multifactorial, making it challenging to identify single biomarkers for diagnosis and treatment.

Key Applications of Biomarkers:

Disease Diagnosis and Monitoring: Biomarkers play a crucial role in the early detection and monitoring of diseases such as cancer, cardiovascular diseases, diabetes, and neurodegenerative disorders. They enable physicians to make informed decisions about treatment strategies and assess patient progress.

Drug Development and Clinical Trials: Biomarkers aid pharmaceutical companies in drug development by identifying potential drug targets, assessing drug efficacy, and predicting patient responses. They streamline the drug development process, reducing costs and time.

Personalized Medicine: With the advent of precision medicine, biomarkers are increasingly used to tailor treatments to individual patients. This approach improves treatment outcomes by accounting for genetic variations and patient-specific characteristics.

Prognostic and Predictive Biomarkers: Prognostic biomarkers provide information about the likely course of a disease, while predictive biomarkers help determine the likelihood of a patient responding to a specific treatment. Both are invaluable in making treatment decisions.

Toxicity Assessment: Biomarkers are employed to assess the safety of drugs and other substances by monitoring their impact on vital organs and physiological processes.

Browse In-depth Market Research Report (300 Pages) on Biomarkers Market:

https://brandessenceresearch.com/healthcare/biomarkers-market-size-worldwide

Segmentation of the Biomarkers Market:

The biomarkers market is segmented based on various criteria, including type, application, and region. This segmentation helps market players and stakeholders understand the market's dynamics and opportunities more effectively.

By Type:

Biomarker Type: Biomarkers can be classified into several categories, including genomic biomarkers, proteomic biomarkers, metabolomic biomarkers, and epigenomic biomarkers, depending on their source and nature.

Disease-Specific Biomarkers: Biomarkers are often specific to particular diseases. For example, prostate-specific antigen (PSA) is a well-known biomarker for prostate cancer.

Competitive Hierarchy:

The prominent players Biomarkers Market Outlook are-

  • Siemens Healthineers
  • Medtronic
  • Hoffman LA Roche Ltd.
  • Abbott Laboratories Nexus-DX
  • Qiagen N.V.
  • PerkinElmer Inc.
  • Lifesign LLC.
  • Merck & Co Inc.
  • Bio-Rad Laboratories
  • EKF Diagnostics Holdings plc
  • Singulex Inc.
  • Signosis Inc
  • BioSims Technologies
  • among others.

Market Segmentation

By Application:

Oncology: The largest segment of the biomarkers market, oncology relies heavily on biomarkers for cancer detection, staging, and treatment selection.

Cardiovascular Disorders: Biomarkers help assess the risk of cardiovascular diseases and guide treatment decisions.

Neurological Disorders: In diseases like Alzheimer's and Parkinson's, biomarkers aid in early diagnosis and tracking disease progression.

Infectious Diseases: Biomarkers are crucial in diagnosing infections and monitoring the effectiveness of treatments.

Other Applications: Biomarkers also find applications in autoimmune diseases, diabetes, and kidney disorders, among others.

By Regional Insights

North America: A major market for biomarkers, driven by advanced healthcare infrastructure and significant investments in research and development.

Europe: Growing adoption of personalized medicine and advancements in biomarker research fuel market growth in Europe.

Asia-Pacific: Increasing healthcare expenditure, a large patient population, and rising awareness are propelling the biomarkers market in this region.

Purchase Copy of This Research Report @:

Checkout_Biomarkers Market

Conclusion:

The biomarkers market is poised for continued growth, driven by technological advancements, the need for personalized medicine, and the rising prevalence of chronic diseases. This market's diverse applications and dynamic nature make it an exciting and ever-evolving field that holds immense potential for healthcare improvements in the years to come. Understanding its scope, segmentation, and market dynamics is crucial for businesses and healthcare professionals operating in this space.

Related Reports:

Navigating Solid Tumor Diseases: Insights and Consulting Services

Demodex Blepharitis: Unveiling Insights and Consulting Services

Unveiling Hope: Navigating Duchenne Muscular Dystrophy (DMD)

Predictive Analytics Powered by AI: Unlocking Insights for the Future of Healthcare

Natural Language Processing (NLP) in Healthcare: Unlocking the Potential

Posluma: A Targeted Oncology Breakthrough in Prostate Cancer Imaging

Fezolinetant by Veozah: Advancing Women's Health by Astellas Pharma Inc.

A Hopeful Sign for Migraine Sufferers: Zavzpret

Rethinking Treatment Options for a Better Future with Hemophilia Gene Therapy

Case study on the Development of Innovative Medicine

Case Study: Software Application for Personalized Care with Data-Driven Insights

Case Study: Cancer Vaccine with Specific Antigens

Combination Trials for Lung Cancer Immunotherapy - Case Study

Using software to manage the supply chain and the inventory

Asset Scouting for Cystic Fibrosis: A Case Study

A Revolutionary Non-Invasive Glucose Monitoring Device Receives Regulatory Approval and Effective Commercialization

Investment in Pancreatic Cancer Chemotherapy

Global Landscape of Lung Cancer Services: Insights and Trends

Monkeypox Unveiled: Symptoms, Transmission, and Preventive Measures

Pneumonia Demystified: Symptoms, Causes, and Prevention Strategies

About Us:

Brandessence Market Research & Consulting Pvt ltd.

Brandessence Market Research publishes market research reports & business insights produced by highly qualified and experienced industry analysts. Our research reports are available in a wide range of industry verticals including aviation, food & beverage, healthcare, ICT, Construction, Chemicals and lot more. Brand Essence Market Research report will be best fit for senior executives, business development managers, marketing managers, consultants, CEOs, CIOs, COOs, and Directors, governments, agencies, organizations and Ph.D. Students. We have a delivery center in Pune, India and our sales office is in London.

Follow Us: LinkedIn  

Contact:

Mr. Vishal Sawant 
Email: vishal@brandessenceresearch.com
Email: Sales@brandessenceresearch.com
Corporate Sales: +44-2038074155 
Asia Office: +917447409162

Logo: https://mma.prnewswire.com/media/1392316/BEMR_Logo.jpg

Modal title

Contact PR Newswire

  • +44 (0)20 7454 5110
    from 8 AM - 5:30 PM GMT
  • General Enquiries
  • Media Enquiries
  • Partnerships

Products

  • Content Distribution
  • Multimedia Services
  • Disclosure Services
  • Cision Communications Cloud®

About

  • About PR Newswire
  • About Cision
  • Partnering Opportunities
  • Careers
  • APAC
  • APAC - Simplified Chinese
  • APAC - Traditional Chinese
  • Brazil
  • Canada
  • Czech
  • Denmark
  • Finland
  • France
  • Germany
  • India
  • Indonesia
  • Israel
  • Japan
  • Korea
  • Mexico
  • Middle East
  • Middle East - Arabic
  • Netherlands
  • Norway
  • Poland
  • Portugal
  • Russia
  • Slovakia
  • Spain
  • Sweden
  • United States
  • Vietnam

My Services

  • All News Releases
  • Customer Portal
  • Resources
  • Blog
  • Journalists
  • Data Privacy

Do not sell or share my personal information:

  • Submit via Privacy@cision.com 
  • Call Privacy toll-free: 877-297-8921

Contact PR Newswire

Products

About

My Services
  • All News Releases
  • Customer Portal
  • Resources
  • Blog
  • Journalists
+44 (0)20 7454 5110
from 8 AM - 5:30 PM GMT
  • Terms of Use
  • Privacy Policy
  • Information Security Policy
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025 PR Newswire Europe Limited. All Rights Reserved. A Cision company.